List view / Grid view
17 April 2015 | By Victoria White
AnaptysBio has announced the advancement of its first-in-class anti-interleukin-36 receptor (IL-36R) antibody, ANB019, into IND-enabling studies.
17 April 2015 | By Victoria White
Takeda and CiRA to work together to develop clinical applications of induced pluripotent stem cells in areas such as diabetes mellitus and immunotherapy...
16 April 2015 | By Victoria White
Innate Pharma and Sanofi are to collaborate to apply Innate’s site-specific conjugation technology to the development of new Antibody Drug Conjugates (ADC)...
16 April 2015 | By Victoria White
Ferring and Institut Pasteur are collaborating aimed at identifying and developing bacteriophages to treat patients with inflammatory bowel disease (IDB)...
15 April 2015 | By Victoria White
Celprogen have developed a novel pharmacological Inhibitor, CEP1430, that is capable of inhibiting the growth of the human pancreatic cancer tumour...
15 April 2015 | By Victoria White
New preclinical data on G1 Therapeutics' lead compound G1T28 will be presented in a minisymposium and a poster session at the AACR Annual Meeting...
15 April 2015 | By Victoria White
Lexicon and Bristol-Myers Squibb have selected a development candidate for neuropathic pain as part of their drug discovery and development alliance...
14 April 2015 | By Victoria White
Hydra Biosciences and Boehringer Ingelheim have entered into a research collaboration with a primary focus on the treatment of renal diseases and disorders...
14 April 2015 | By Victoria White
Preclinical results on ALN-AT3, an investigational RNAi therapeutic targeting AT for the treatment of haemophilia and RBD, have been published...
14 April 2015 | By Victoria White
BI-1206 has shown success in overcoming resistance to monoclonal antibodies like rituximab, currently used to treat different types of cancer...
13 April 2015 | By Victoria White
AstraZeneca and PatientsLikeMe have signed an agreement to provide AZ with access to PatientsLikeMe’s global network to shape future medicine development...
13 April 2015 | By Victoria White
Medivir and CRT have announced a partnership to develop a new class of drugs that has shown promise for treating a range of different cancers...
13 April 2015 | By Victoria White
Bayer HealthCare has expanded its collaboration with the Broad Institute to include cardiovascular genomics and drug discovery...
13 April 2015 | By Victoria White
Eisai and Genomics are to collaborate to use Genomics' statistical analyses of large-scale multi-phenotype data to inform Eisai's drug discovery process...
9 April 2015 | By Victoria White
Novogen has announced that studies conducted at UQDI revealed that experimental drug Anisina killed melanoma cells irrespective of their mutational status...
